Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: a phase II trial.

@article{Downs2011IfosfamidePA,
  title={Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: a phase II trial.},
  author={Levi S. Downs and Justin C. Chura and Peter A. Argenta and Patricia L. Judson and Rahel Ghebre and Melissa A. Geller and Linda F. Carson},
  journal={Gynecologic oncology},
  year={2011},
  volume={120 2},
  pages={
          265-9
        }
}
OBJECTIVES (1) To determine the response rate of advanced, recurrent, or persistent carcinoma of the cervix to ifosfamide, paclitaxel, and carboplatin chemotherapy; (2) to determine the progression free interval and survival rate in patients treated with this regimen; (3) to describe the toxicities associated with this regimen; and (4) to evaluate the quality of life of patients while on treatment. METHODS Eligible patients had histologically proven stage IVB, recurrent, or persistent… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 19 REFERENCES

Cervical cancer.

VIEW 2 EXCERPTS

Similar Papers

Loading similar papers…